Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
Authors
Keywords
-
Journal
BLOOD
Volume 123, Issue 4, Pages 530-540
Publisher
American Society of Hematology
Online
2013-10-31
DOI
10.1182/blood-2013-07-517649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection
- (2013) Laura R. Wasil et al. PLoS One
- Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A
- (2012) Jamie L. Dargart et al. ANTIVIRAL RESEARCH
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
- (2012) Zuqin Nie et al. CELL
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- p27kip1Protein Levels Reflect a Nexus of Oncogenic Signaling during Cell Transformation
- (2012) Jeffrey P. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma
- (2011) K. T. Bieging et al. BLOOD
- SKP2 Oncogene Is a Direct MYC Target Gene and MYC Down-regulates p27KIP1through SKP2 in Human Leukemia Cells
- (2011) Gabriel Bretones et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapamycin Reverses Splenomegaly and Inhibits Tumor Development in a Transgenic Model of Epstein-Barr Virus-Related Burkitt's Lymphoma
- (2011) O. Cen et al. MOLECULAR CANCER THERAPEUTICS
- Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro
- (2011) M P Serres et al. ONCOGENE
- Deficiency of Rap1-Binding Protein RAPL Causes Lymphoproliferative Disorders through Mislocalization of p27kip1
- (2010) Koko Katagiri et al. IMMUNITY
- Skp2 Directs Myc-Mediated Suppression of p27Kip1 yet Has Modest Effects on Myc-Driven Lymphomagenesis
- (2010) J. B. Old et al. MOLECULAR CANCER RESEARCH
- Epstein–Barr virus LMP2A accelerates MYC-induced lymphomagenesis
- (2009) R Bultema et al. ONCOGENE
- Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
- (2009) K. T. Bieging et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
- (2009) Martin J. Allday SEMINARS IN CANCER BIOLOGY
- c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27Kip1 cyclin dependent kinase inhibitor
- (2008) Vidyalakshmi Chandramohan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis
- (2008) S. P. Garrison et al. MOLECULAR AND CELLULAR BIOLOGY
- The B Cell Antigen Receptor and Overexpression of MYC Can Cooperate in the Genesis of B Cell Lymphomas
- (2008) Yosef Refaeli et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started